Immunogenicity and Safety Following a Homologous Booster Dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): A Phase 2 Randomized Placebo-Controlled Trial
View ORCID ProfileRaburn Mallory, Neil Formica, Susan Pfeiffer, Bethanie Wilkinson, Alex Marcheschi, Gary Albert, Heather McFall, Michelle Robinson, Joyce S. Plested, Mingzhu Zhu, Shane Cloney-Clark, Bin Zhou, Gordon Chau, Andreana Robertson, Sonia Maciejewski, Gale Smith, Nita Patel, Gregory M. Glenn, Filip Dubovsky, for the Novavax Inc. 2019nCoV-101 Study Group
doi: https://doi.org/10.1101/2021.12.23.21267374
Raburn Mallory
Novavax, Inc
Neil Formica
Novavax, Inc
Susan Pfeiffer
Novavax, Inc
Bethanie Wilkinson
Novavax, Inc
Alex Marcheschi
Novavax, Inc
Gary Albert
Novavax, Inc
Heather McFall
Novavax, Inc
Michelle Robinson
Novavax, Inc
Joyce S. Plested
Novavax, Inc
Mingzhu Zhu
Novavax, Inc
Shane Cloney-Clark
Novavax, Inc
Bin Zhou
Novavax, Inc
Gordon Chau
Novavax, Inc
Andreana Robertson
Novavax, Inc
Sonia Maciejewski
Novavax, Inc
Gale Smith
Novavax, Inc
Nita Patel
Novavax, Inc
Gregory M. Glenn
Novavax, Inc
Filip Dubovsky
Novavax, Inc
Novavax, Inc

Article usage
Posted December 25, 2021.
Immunogenicity and Safety Following a Homologous Booster Dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): A Phase 2 Randomized Placebo-Controlled Trial
Raburn Mallory, Neil Formica, Susan Pfeiffer, Bethanie Wilkinson, Alex Marcheschi, Gary Albert, Heather McFall, Michelle Robinson, Joyce S. Plested, Mingzhu Zhu, Shane Cloney-Clark, Bin Zhou, Gordon Chau, Andreana Robertson, Sonia Maciejewski, Gale Smith, Nita Patel, Gregory M. Glenn, Filip Dubovsky, for the Novavax Inc. 2019nCoV-101 Study Group
medRxiv 2021.12.23.21267374; doi: https://doi.org/10.1101/2021.12.23.21267374
Immunogenicity and Safety Following a Homologous Booster Dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): A Phase 2 Randomized Placebo-Controlled Trial
Raburn Mallory, Neil Formica, Susan Pfeiffer, Bethanie Wilkinson, Alex Marcheschi, Gary Albert, Heather McFall, Michelle Robinson, Joyce S. Plested, Mingzhu Zhu, Shane Cloney-Clark, Bin Zhou, Gordon Chau, Andreana Robertson, Sonia Maciejewski, Gale Smith, Nita Patel, Gregory M. Glenn, Filip Dubovsky, for the Novavax Inc. 2019nCoV-101 Study Group
medRxiv 2021.12.23.21267374; doi: https://doi.org/10.1101/2021.12.23.21267374
Subject Area
Subject Areas
- Addiction Medicine (162)
- Allergy and Immunology (416)
- Anesthesia (91)
- Cardiovascular Medicine (862)
- Dermatology (98)
- Emergency Medicine (251)
- Epidemiology (8570)
- Gastroenterology (387)
- Genetic and Genomic Medicine (1756)
- Geriatric Medicine (167)
- Health Economics (373)
- Health Informatics (1249)
- Health Policy (622)
- Hematology (196)
- HIV/AIDS (378)
- Medical Education (192)
- Medical Ethics (51)
- Nephrology (212)
- Neurology (1680)
- Nursing (97)
- Nutrition (252)
- Oncology (930)
- Ophthalmology (263)
- Orthopedics (102)
- Otolaryngology (172)
- Pain Medicine (114)
- Palliative Medicine (40)
- Pathology (253)
- Pediatrics (536)
- Primary Care Research (209)
- Public and Global Health (3851)
- Radiology and Imaging (624)
- Respiratory Medicine (521)
- Rheumatology (208)
- Sports Medicine (158)
- Surgery (191)
- Toxicology (36)
- Transplantation (101)
- Urology (76)